WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.

MLA

Zhou, Qianghua, et al. “WD Repeat Domain 5 Promotes Chemoresistance and Programmed Death-Ligand 1 Expression in Prostate Cancer.” Theranostics, vol. 11, no. 10, Mar. 2021, pp. 4809–24. EBSCOhost, https://doi.org/10.7150/thno.55814.

APA

Zhou, Q., Chen, X., He, H., Peng, S., Zhang, Y., Zhang, J., Cheng, L., Liu, S., Huang, M., Xie, R., Lin, T., & Huang, J. (2021). WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer. Theranostics, 11(10), 4809–4824. https://doi.org/10.7150/thno.55814

Chicago

Zhou, Qianghua, Xu Chen, Haixia He, Shengmeng Peng, Yangjie Zhang, Jingtong Zhang, Liang Cheng, et al. 2021. “WD Repeat Domain 5 Promotes Chemoresistance and Programmed Death-Ligand 1 Expression in Prostate Cancer.” Theranostics 11 (10): 4809–24. doi:10.7150/thno.55814.